Asia Morning Nov 17
The Russell 2000 Index (+2.37%) also closes at record high...
Share this:
On Monday, U.S. stocks maintained upward momentum pushing the Dow Jones Industrial Average (+470 points or 1.60% to 29950) and the S&P 500 (+41 points or 1.16% to 3626) to record levels. The Nasdaq 100 rose 75 points (+0.63%) to 12013.
At the same time, the Russell 2000 Index (+41 points or 2.37% to 1785) also closed at record high.
S&P 500 Index (Daily Chart) : Fresh Record High
Sources: GAIN Capital, TradingView
The key market driver was Moderna's (MRNA +9.58%) announcement of positive trial results of its COVID-19 vaccine.
Energy (+6.5%), Automobiles & Components (+3.01%) and Banks (+2.95%) sectors performed the best. Energy companies such as Schlumberger (SLB +10.89%), National Oilwell Varco (NOV +9.38%) and HollyFrontier (HFC +9.24%) were top gainers along with a 3% gain in as oil prices.
Approximately 87% (82% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 86% (80% in the prior session) were trading above their 20-day moving average.
In after-market hours, Tesla (TSLA) soared over 10% after S&P Dow Jones Indices announced that the stock will join the S&P 500 Index in December.
European stocks were broadly higher. The Stoxx Europe 600 rose 1.18%, Germany's DAX added 0.47%, France's CAC 40 jumped 1.70%, and the U.K.'s FTSE 100 was up 1.66%.
U.S. Treasury prices remained under pressure, as the benchmark 10-year Treasury yield climbed further to 0.904% from 0.893% Friday.
Spot gold edged up to $1,889 an ounce.
Oil prices jumped as economic recovery hopes were boosted by positive news concerning Moderna's vaccine candidate. U.S. WTI crude futures (December) jumped $1.27 (+3.16%) to $41.4 a barrel.
The U.S. dollar kept weakening against other major currencies as investors' risk appetite was enlarged by another positive development on a COVID-19 vaccine. The ICE Dollar Index slipped 0.17% to 92.55.
EUR/USD was up for a third session rising 0.15% to 1.1851.
USD/JPY edged down to 104.58, testing support at its 20-day moving average. Official data showed that Japan's 3Q GDP rose at an annualized rate of 21.4% on quarter (+18.9% expected).
GBP/USD closed flat at 1.3197.
Commodity-related currencies strengthened against the greenback. AUD/USD jumped 0.69% to 0.7320, up for a second session.
USD/CAD slid 0.48% to 1.3074.
At the same time, the Russell 2000 Index (+41 points or 2.37% to 1785) also closed at record high.
S&P 500 Index (Daily Chart) : Fresh Record High
Sources: GAIN Capital, TradingView
The key market driver was Moderna's (MRNA +9.58%) announcement of positive trial results of its COVID-19 vaccine.
Energy (+6.5%), Automobiles & Components (+3.01%) and Banks (+2.95%) sectors performed the best. Energy companies such as Schlumberger (SLB +10.89%), National Oilwell Varco (NOV +9.38%) and HollyFrontier (HFC +9.24%) were top gainers along with a 3% gain in as oil prices.
Approximately 87% (82% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 86% (80% in the prior session) were trading above their 20-day moving average.
In after-market hours, Tesla (TSLA) soared over 10% after S&P Dow Jones Indices announced that the stock will join the S&P 500 Index in December.
European stocks were broadly higher. The Stoxx Europe 600 rose 1.18%, Germany's DAX added 0.47%, France's CAC 40 jumped 1.70%, and the U.K.'s FTSE 100 was up 1.66%.
U.S. Treasury prices remained under pressure, as the benchmark 10-year Treasury yield climbed further to 0.904% from 0.893% Friday.
Spot gold edged up to $1,889 an ounce.
Oil prices jumped as economic recovery hopes were boosted by positive news concerning Moderna's vaccine candidate. U.S. WTI crude futures (December) jumped $1.27 (+3.16%) to $41.4 a barrel.
The U.S. dollar kept weakening against other major currencies as investors' risk appetite was enlarged by another positive development on a COVID-19 vaccine. The ICE Dollar Index slipped 0.17% to 92.55.
EUR/USD was up for a third session rising 0.15% to 1.1851.
USD/JPY edged down to 104.58, testing support at its 20-day moving average. Official data showed that Japan's 3Q GDP rose at an annualized rate of 21.4% on quarter (+18.9% expected).
GBP/USD closed flat at 1.3197.
Commodity-related currencies strengthened against the greenback. AUD/USD jumped 0.69% to 0.7320, up for a second session.
USD/CAD slid 0.48% to 1.3074.
On Monday, U.S. stocks maintained upward momentum pushing the Dow Jones Industrial Average (+470 points or 1.60% to 29950) and the S&P 500 (+41 points or 1.16% to 3626) to record levels. The Nasdaq 100 rose 75 points (+0.63%) to 12013.
At the same time, the Russell 2000 Index (+41 points or 2.37% to 1785) also closed at record high.
S&P 500 Index (Daily Chart) : Fresh Record High
Sources: GAIN Capital, TradingView
The key market driver was Moderna's (MRNA +9.58%) announcement of positive trial results of its COVID-19 vaccine.
Energy (+6.5%), Automobiles & Components (+3.01%) and Banks (+2.95%) sectors performed the best. Energy companies such as Schlumberger (SLB +10.89%), National Oilwell Varco (NOV +9.38%) and HollyFrontier (HFC +9.24%) were top gainers along with a 3% gain in as oil prices.
Approximately 87% (82% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 86% (80% in the prior session) were trading above their 20-day moving average.
In after-market hours, Tesla (TSLA) soared over 10% after S&P Dow Jones Indices announced that the stock will join the S&P 500 Index in December.
European stocks were broadly higher. The Stoxx Europe 600 rose 1.18%, Germany's DAX added 0.47%, France's CAC 40 jumped 1.70%, and the U.K.'s FTSE 100 was up 1.66%.
U.S. Treasury prices remained under pressure, as the benchmark 10-year Treasury yield climbed further to 0.904% from 0.893% Friday.
Spot gold edged up to $1,889 an ounce.
Oil prices jumped as economic recovery hopes were boosted by positive news concerning Moderna's vaccine candidate. U.S. WTI crude futures (December) jumped $1.27 (+3.16%) to $41.4 a barrel.
The U.S. dollar kept weakening against other major currencies as investors' risk appetite was enlarged by another positive development on a COVID-19 vaccine. The ICE Dollar Index slipped 0.17% to 92.55.
EUR/USD was up for a third session rising 0.15% to 1.1851.
USD/JPY edged down to 104.58, testing support at its 20-day moving average. Official data showed that Japan's 3Q GDP rose at an annualized rate of 21.4% on quarter (+18.9% expected).
GBP/USD closed flat at 1.3197.
Commodity-related currencies strengthened against the greenback. AUD/USD jumped 0.69% to 0.7320, up for a second session.
USD/CAD slid 0.48% to 1.3074.
At the same time, the Russell 2000 Index (+41 points or 2.37% to 1785) also closed at record high.
S&P 500 Index (Daily Chart) : Fresh Record High
Sources: GAIN Capital, TradingView
The key market driver was Moderna's (MRNA +9.58%) announcement of positive trial results of its COVID-19 vaccine.
Energy (+6.5%), Automobiles & Components (+3.01%) and Banks (+2.95%) sectors performed the best. Energy companies such as Schlumberger (SLB +10.89%), National Oilwell Varco (NOV +9.38%) and HollyFrontier (HFC +9.24%) were top gainers along with a 3% gain in as oil prices.
Approximately 87% (82% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 86% (80% in the prior session) were trading above their 20-day moving average.
In after-market hours, Tesla (TSLA) soared over 10% after S&P Dow Jones Indices announced that the stock will join the S&P 500 Index in December.
European stocks were broadly higher. The Stoxx Europe 600 rose 1.18%, Germany's DAX added 0.47%, France's CAC 40 jumped 1.70%, and the U.K.'s FTSE 100 was up 1.66%.
U.S. Treasury prices remained under pressure, as the benchmark 10-year Treasury yield climbed further to 0.904% from 0.893% Friday.
Spot gold edged up to $1,889 an ounce.
Oil prices jumped as economic recovery hopes were boosted by positive news concerning Moderna's vaccine candidate. U.S. WTI crude futures (December) jumped $1.27 (+3.16%) to $41.4 a barrel.
The U.S. dollar kept weakening against other major currencies as investors' risk appetite was enlarged by another positive development on a COVID-19 vaccine. The ICE Dollar Index slipped 0.17% to 92.55.
EUR/USD was up for a third session rising 0.15% to 1.1851.
USD/JPY edged down to 104.58, testing support at its 20-day moving average. Official data showed that Japan's 3Q GDP rose at an annualized rate of 21.4% on quarter (+18.9% expected).
GBP/USD closed flat at 1.3197.
Commodity-related currencies strengthened against the greenback. AUD/USD jumped 0.69% to 0.7320, up for a second session.
USD/CAD slid 0.48% to 1.3074.
Related tags:
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
S&P 500 forecast: Stocks extend drop as correction risks grow
US and global equity markets have extended Wednesday’s sell-off, with Wall Street opening lower after a weak handover from Asia and Europe. The deterioration in risk appetite has been spreading across global markets. The dollar was firmer, Treasury yields were holding onto yesterday’s gains, while gold, silver and bitcoin were all under pressure alongside equities and major currencies.
Nikkei threatens breakout as tech rebound broadens
Breakouts across the SOX and Nasdaq are being matched by rebounds across Asia, with the Nikkei now threatening to join the move.
Nasdaq 100 Forecast: Confidence Returns as the Index Challenges Record Highs
The trading week is getting underway with renewed bullish momentum across Nasdaq. This is reflected in today's session, where the index has gained more than 2.5%, highlighting a buying bias that has not been observed with this level of strength in several weeks.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.